The polymerase chain reaction (PCR) is a new diagnostic technique for the detection of enteroviral infection; however, it currently provides only qualitative results. The aim of this study was to adapt PCR for the accurate quantitation of enteroviral RNA in clinical specimens. For this purpose, we designed a standard RNA which was homologous to sequences at the 5' end of the coxsackie B3 enterovirus genome but contained a single-base-pair mutation which created a novel internal restriction site. A significant recent advance in the diagnosis of enteroviral infection has been the application of polymerase chain reaction (PCR) technology (3, 10, 14, 22, 35) . Computerassisted alignment of enteroviral nucleotide sequences has revealed a highly conserved 5' nontranslated region (NTR) (12, 13, (16) (17) (18) 29) . Amplification of this region of the enteroviral genome has made it possible to detect a broad array of serotypes with a degree of sensitivity and rapidity unequalled by the conventional techniques of cell culture, immunoassay, and nucleic acid hybridization.
readily be applied to the diagnosis of enteroviral infection.
The genus Enterovirus consists of positive-strand RNA viruses and is subdivided into five different groups: poliovirus, coxsackievirus group A (CVA), coxsackievirus group B (CVB), echovirus (EV), and numbered enterovirus. There are 68 serotypes which have been associated with disease in humans. While often characterized by subclinical syndromes, enteroviral infection has also been reported for a number of serious diseases. Clinical manifestations range from minor febrile illness to life-threatening conditions such as myocarditis, dilated cardiomyopathy, meningitis, and poliomyelitis (19) .
A significant recent advance in the diagnosis of enteroviral infection has been the application of polymerase chain reaction (PCR) technology (3, 10, 14, 22, 35) . Computerassisted alignment of enteroviral nucleotide sequences has revealed a highly conserved 5' nontranslated region (NTR) (12, 13, (16) (17) (18) 29) . Amplification of this region of the enteroviral genome has made it possible to detect a broad array of serotypes with a degree of sensitivity and rapidity unequalled by the conventional techniques of cell culture, immunoassay, and nucleic acid hybridization.
Although PCR diagnosis provides notable qualitative results, it has not been used for quantitative information on enteroviruses in clinical specimens. Quantitation could provide valuable insight into patient prognosis and response to treatments and into the pathogenesis of enteroviral infection.
The principle constraint in quantitation of PCR products is inherent in the amplification process. That is, minute variations in PCR can make comparisons of product yield unreliable (7, 30) . The purpose of this study was The oligonucleotides were derived from the conserved sequences in the 5' NTR of the enteroviral genome. Primers A and D and probe P1 were previously described as E2, El, and E3, respectively (3). Primers B and C are novel. Primer B is identical to positions 529 to 546 in the CVB3 genomic sequence, with the exception of a single-base-pair change of an A to a T at position 538. Primer C is complementary to primer B. The sequence of each oligonucleotide is shown in Fig. 1 .
RNA purification. Normal CSF was generously supplied by the Department of Hematology, Hospital for Sick Children, Toronto, Canada. The CSF was tested by PCR for enteroviral infection. Enterovirus-negative CSF from several patients was pooled.
CVB3 obtained from cell culture supernatants was added to 0.1-ml aliquots of the pooled CSF at titers ranging from 106 to 101 TCID50, depending on the experiment. Viral RNA was then extracted by the acid guanidinium thiocyanatephenol-chloroform method (4 Analysis by electrophoresis, Southern transfer, and hybridization. A 10-,ul aliquot of the PCR product was electrophoresed at 100 V onto 1.6% EtBr-stained agarose gels in 1 x TAE running buffer (40 mM Tris acetate, 1 mM EDTA, 0.0002 ,g of EtBr per ,ul). DNA was detected by illumination under a UV light (302 nm).
To confirm specificity, Southern hybridization was performed by the method described previously (31) . Briefly, the DNA bands were transferred and denatured onto Hybond N+ nylon membranes (Amersham Canada Ltd.) for 2 h in 0.4 M sodium hydroxide. The probe P1, 5' end labelled with [-y-32P]ATP (3,000 Ci/mol; DuPont), was used for hybridization.
Site-directed mutagenesis of CVB3 by overlap extension. A synthetic panenteroviral standard was constructed for use in competitive PCR (1, 8, 9) . The standard was designed so that it was identical to the CVB3 genome between primer sites A and D, with the exception of a single internal base pair mutation. This mutation created a unique restriction site for BamHI enzyme in the standard. To create this standard, CVB3 fragments were generated from one PCR mixture containing primers A and C and from a second reaction mixture containing primers B and D. The fragments were isolated from their reaction mixtures by size-fractioning electrophoresis on an agarose gel. The bands of appropriate size were cut from the gel and purified by using the Sephaglas Band Prep Kit (Pharmacia) according to the manufacturer's specifications. The two purified fragments (A-C and B-D) were combined and then amplified by PCR with outside primers A and D.
Cloning of the standard PCR fragment. The synthetic standard DNA fragment was first cloned into a TA cloning vector (Invitrogen Corp.) according to the manufacturer's directions. This kit allowed direct insertion of the PCR product into the vector. The insert was then subcloned from the SpeI and NotI vector restriction sites into the plasmid pBluescript II KS' (Stratagene), which contained a T7 RNA polymerase recognition site. The resulting plasmid, pBlue CVB3, was transformed into Escherichia coli cells (Invitrogen), which were then plated onto Luria-Bertani agar plates containing ampicillin (50 ,ug/ml) and 25 pl of X-Gal (5-bromo-4-chloro-3-indolyl-,-D-galactopyranoside) (40 mg/ml; Boehringer Mannheim).
The presence of a standard insert containing the BamHI mutation was verified by sequencing by the one-step reaction protocol for automated DNA sequencing with T7 DNA polymerase (Pharmacia LKB Biotechnology) and by restriction enzyme digestion. RNA Specificity of the competitive PCR assay-Southern blots and controls. To demonstrate the specificity of the PCR assay, the samples were transferred from the gels to nylon membranes for Southern blot hybridization. Extraneous bands were not detected (Fig. 3) . The Southern blot also demonstrated that the panenteroviral probe P1 was capable of hybridizing to the novel standard band. Product bands were slightly more distinct at the lower viral titers. This would be expected, since the use of radioactivity allows for better detection of small quantities of DNA than EtBr analysis.
In all experiments, exclusive sample controls were run (standard or viral RNA only) to demonstrate that the standard product band was distinct from the viral product band ( Fig. 2 and 3, lanes 12 and 13) . The efficiency of the restriction enzyme for homodimeric DNA digestion could also be monitored through these control lanes. Water controls monitoring sample contamination were clearly negative ( Fig. 2 and 3, lanes 14) .
Quantitation, sensitivity, and fidelity of the competitive PCR assay. Duplicate samples amplified by PCR in the presence of [a-3 P]dCTP were used for quantitation. Bands corresponding to CVB3 and the standard product were individually excised from gels, and the amount of radioactivity was determined. Figure 4 shows each product ratio (CVB3/standard) plotted against the quantity of standard present in the sample tube. Using the internal standard, we were able to quantitate the enteroviral RNA at all titers tested, from 6,000 to Fig. 2 and 3 . Duplicate samples were amplified in the presence of [a-32P]dCTP, digested with BamHI, and electrophoresed onto 1.6% EtBr-agarose gels. Bands corresponding to the viral and standard DNA were individually excised, and the amount of radioactivity was determined by scintillation counting. The ratio of radioactivity was plotted against the known concentration of the enteroviral standard in each sample tube.
transcription, and the conditions of PCR (7, 30) . To circumvent these problems, we have used an RNA standard which is coamplified with the viral RNA. Introducing the standard template to the same reaction tube allowed us to internally control the variables associated with PCR detection of viral RNA in clinical specimens.
Although an internal standard can control for variables affecting the reaction mixture, the potential differences in amplification efficiency between the standard and viral templates must also be considered (7, 30) . Compared with viral template, an unrelated standard may exhibit differences in melting temperature, optimal magnesium concentration, and primer specificity. Moreover, length and sequence variations can contribute to differential declines in reaction rates. We have avoided these problems by designing a standard RNA which is closely related to the amplified region of the enteroviral genome. Our standard is the same length and contains the same primer binding sites A and D as CVB3 genomic RNA, but it differs internally by 1 bp, creating the unique BamHI restriction site. Since the standard and viral templates are virtually identical, the amplification efficiencies of the two should be equal. By this approach, we were able to compare the final yields of both PCR products and determine the starting quantity of viral RNA.
In the past, cell culture techniques have been used for quantitation of enteroviruses in clinical specimens (32) . In CSF samples, the titers ranged from 101 to 103. Throat swabs and stool samples may have titers as high as 105 during the first week of infection; however, the most common quantities found during the following weeks of infection were in the range of 101 to 102 titerable viruses. Although these quantities are easily detected by growth in cell culture, this form of quantitation poses some difficulties. Quantitation can be laborious and slow, since there is no single cell culture system capable of detecting all enteroviruses. Within a single cell line, enteroviruses can show considerable variation in plaquing efficiency and the CVA viruses fail to produce a cytopathic effect in most culture systems.
Quantitation by using cell culture is also limited to clinical specimens containing titerable virus. However, there have been recent reports describing the persistence of nontiterable enteroviral RNA in chronic diseases such as dilated cardiomyopathy (14, 15) , polymyositis (2), and chronic fatigue syndrome (33) and in experimental murine models of virus-induced heart disease (5, 31), and for these, a quantitative technique capable of detecting viral genome is required. In an elegant series of experiments, radiolabelled cDNA, RNA, and oligomeric DNA probes were hybridized to titered enterovirus or clinical specimens blotted onto nylon membrane filters (23) (24) (25) (26) ; however, even the best of these methods detected only 10 pg of RNA. In situ hybridization, a more sensitive technique, has reportedly detected 10 to 100 enteroviral genomes (34) , but it is technically difficult and not appropriate for rapid application to large numbers of clinical samples.
Quantitation of enteroviruses in clinical specimens by competitive PCR offers many advantages over the techniques listed above. In contrast to cell culture methodology, competitive PCR allows quantitation of both infectious virions and persistent but unculturable viral RNA and it can easily be performed within a single day. Moreover, the level of sensitivity surpasses that of immunoassay or nucleic acid probe hybridization.
In this study, we were able to quantitate CVB3 at titers as low as 15 TCID50 (<1 pg). Our level of detection was consistent with the most common levels of virus reported for clinical specimens. We were also able to clearly distinguish between fourfold differences in viral titer, even at the level of 15 TCID50. However, the method did appear to be limited to viral titers of at least 101 TCID50, which may reflect the limits of PCR with an internal standard. Quantitation of cellular RNA by competitive PCR has been reported previously (1, 7, 30) . However, quantitation of enteroviral RNA by competitive PCR requires consideration of several additional factors. First, although the standard can serve as a control during cDNA synthesis and PCR, it cannot control for the loss of enteroviral RNA which occurs during nucleic acid purification. In order to address the issue of reproducibility, we have quantitated 6,000 TCID50 of CVB3 from two different preparations of RNA and found less than a twofold difference in quantity (results not shown). However, it is conceivable that the yield of RNA can vary with each preparation, particularly as reagents are replaced, or can depend on the method of RNA purification used. To control for this, one positive sample should be compared with a standardized graph.
Another factor to consider is that the standard quantitates at the 5' end of the viral genome; however, there may be variability in the representation of this section, particularly in samples from tissues in which there is viral persistence. In such cases, variability may be caused by the specific degradation of RNA or by an abundance of incomplete or defective viral particles. The relative persistence of different regions of the enteroviral genome in infected tissues remains to be established.
Third, the engineered restriction site in the standard RNA is unique compared with known enteroviral sequences. However, since the RNA sequence of most enteroviruses remains unknown, one confirmational control in which the enterovirus is amplified in the absence of standard should always be run at the same time and subjected to enzyme digestion.
Quantitation of enteroviral RNA by competitive PCR can be routinely performed. The standard fragment has been cloned into E. coli; consequently, it is relatively easy to store, and can be grown as required in large quantities in most microbiology laboratories. We have also found that the transcribed standard RNA stored in aliquots at -70°C in 5 M ammonium acetate and 70% ethanol is very stable. However, the use of radioactivity for routine applications does warrant further consideration. We chose to do a radiolabel incorporation with [a-32P]dCTP followed by electrophoresis, band excision, and direct scintillation counting because we felt that this method was the most accurate and the least time-consuming. There are alternative techniques for product analysis, though, particularly if scanners are available. Autoradiography followed by densitometry is one alternative, which also affords the option of performing the assay in the absence of radioactivity if a biotinylated primer is used in the PCR. Direct scanning of the EtBr-stained gels also circumvents the use of radioactivity, particularly when the gel bands show high levels of intensity and distinction.
The We conclude that quantitative PCR detection of enteroviruses by using panenteroviral primers and a mutated standard is feasible, accurate, and sensitive. This technique may have important application in the clinical diagnosis and prognosis of enteroviral infections.
